**Background**
The serotonin (5-hydroxytryptamine, 5-HT) receptor family consists of several subtypes that play critical roles in regulating mood, cognition, and nociception. Among these, the 5-HT 1E and 5-HT 1F receptors are of particular interest due to their specific distribution in the mammalian brain and cerebral vasculature. Understanding the pharmacological profiles of these receptors is essential for developing targeted therapies for neurological disorders and pain management. Given the complexity of serotonergic signaling, the development of highly selective ligands is necessary to avoid off-target effects associated with other 5-HT and dopamine receptors. In this context, we will introduce a potent 5-HT 1E/1F receptor agonist – BRL 54443.
**Definition**
BRL 54443 is a potent 5-HT 1E/1F receptor agonist with high binding affinity, exhibiting Ki values of 1.1 nM for the 5-HT 1E receptor and 0.7 nM for the 5-HT 1F receptor.
**In Vitro and In Vivo Studies**
The BRL 54443 description highlights its exceptional selectivity, displaying more than 30-fold selectivity over other 5-HT and dopamine receptors. Regarding BRL 54443 in vitro activity, the compound shows low affinity for 5-HT 1A (63 nM), 5-HT 1B (126 nM), 5-HT 1D (63 nM), 5-HT 2A (1259 nM), 5-HT 2B (100 nM), and 5-HT 2C (316 nM), with negligible binding to 5-HT 6 and 5-HT 7 receptors (>10,000 nM). In DG membranes, BRL 54443 selectively stimulates 5-HT 1E receptors and potently inhibits forskolin-dependent cAMP production with an IC50 of 14 nM. Additionally, it has been shown to induce contraction with a -log EC50 of 6.52.
Evaluation of BRL 54443 In Vivo has demonstrated its potential in antinociception research. In rat models, the peripheral administration of BRL 54443 (3-300 μg/paw) to the ipsilateral side significantly reduced formalin-induced flinching, whereas contralateral administration did not produce the same effect. These findings suggest a peripheral role for 5-HT 1E/1F receptors in modulating pain responses. For researchers seeking detailed BRL 54443 technical information, these results underscore the compound’s utility as a selective tool for studying serotonergic pathways. In conclusion, BRL 54443 is a highly selective 5-HT 1E/1F receptor agonist suitable for pharmacological research in nociception and signal transduction.
Keywords
BRL 54443, 57477-39-1, BRL54443, BRL-54443, 5-HT Receptor, Serotonin Receptor, 5-hydroxytryptamine Receptor, Inhibitor, inhibitor, inhibit
References
[1] Klein MT, et al. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. J Pharmacol Exp Ther. 2011 Jun;337(3):860-867.
[2] McKune CM, et al. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J Pharmacol Exp Ther. 2001 Apr;297(1):88-95.
[3] Klein MT, et al. Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study. Br J Pharmacol. 2012 Jun;166(4):1290-302.
[4] Granados-Soto V, et al. The role of peripheral 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F serotonergic receptors in the reduction of nociception in rats. Neuroscience. 2010 Jan 20;165(2):561-8.